Skip to main content
Caplight Logo









Matibabu

Matibabu

Private
KampalaHealthcare & Life Scienceshttps://www.matibabu.io/

Last Round

Grant

Jun 13, 2018

Total Funding Raised

$53,000

Company Overview

Matibabu operates in Healthcare & Life Sciences and is based in Kampala. Its latest recorded funding round was a Grant round in June 2018.

Matibabu is a health diagnostics company that develops portable, non-invasive hardware devices and software solutions for the rapid detection of malaria.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Matibabu Comparables

Compare Matibabu with similar companies based on industry and business-model similarity.

Matibabu comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fyodor Biotechnologies
81%
Hemex Health
79%
Atomo Diagnostics Ltd
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Matibabu Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 13, 2018
GrantMay 30, 2017
GrantJul 20, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Matibabu Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 844% MoM, reaching 1.1K.

  • Apr 14, 2025

    Grew 43% QoQ, from 7 to 10 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Matibabu Filings

Explore SEC and related filing metadata, where available.

Matibabu filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Matibabu's valuation, stock price, and market status.

Is Matibabu a public or private company?

Matibabu is a private company.

What is the current stock price of Matibabu?

Matibabu is a private company, so its shares have no public market price. Caplight tracks Matibabu's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Matibabu worth (valuation)?

Valuation information for Matibabu is not publicly available.

Can I buy Matibabu stock?

Matibabu shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Matibabu's last funding round?

Matibabu's most recent funding round was Grant on June 13, 2018.

Who are the main investors in Matibabu?

Key investors in Matibabu include ASME Innovation Showcase (ISHOW), Villgro Africa, Government of Uganda, Royal Academy of Engineering.

Will Matibabu IPO soon?

No public IPO plans have been announced for Matibabu.

How can I track Matibabu secondary market activity?

Caplight tracks bids, offers, and trades in Matibabu's shares on secondary markets.

Firmographic Details

HeadquartersKampala
Employee Range1
Year Founded2013
Last FundingJun 13, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?